Skip to content

Impact of Topical Antiadhesion Therapy on Wound Healing and Postoperative Pain After Anal Surgery

Impact of Topical Antiadhesion Therapy on Wound Healing and Postoperative Pain After Anal Surgery: A Randomized Double-blinded Controlled Study

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04275596
Enrollment
50
Registered
2020-02-19
Start date
2020-02-10
Completion date
2021-05-30
Last updated
2020-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal Wound

Brief summary

2QR-complex is a patented molecule extracted from Aloe vera barbadensis leaves that blocks the adhesion of pathogenic microbes to human epithelial cells and tissues \[9\]. Anti-adhesion therapy such as 2QR-complex has been suggested as an alternative to antibiotics in the treatment of bacterial infections. 2QR-complex based products have already shown comparable efficacy to antibiotics in treating mucosal infections such as bacterial vaginosis. In the present study we aim to assess the efficacy of 2QR-complex in pain relief and promotion of anal wound healing after anal surgery. We presumed that anal discomfort and prolonged healing after surgery for anal fissure, fistula, and hemorrhoids may in part be due to contamination of the wound with fecal bacteria that colonize at the surgical site. Therefore, we assumed that the use of topical anti-adhesive 2QR-complex-based product may serve to minimize this negative impact on wound healing.

Interventions

DRUG2QR complex

Application of topical gel containing 2QR complex on the anal wound until complete wound healing

DRUGPlacebo

Application of topical placebo on the anal wound until complete wound healing

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients of either sex with simple anal fistula, chronic anal fissure, or grade III/IV hemorrhoids will be included.

Exclusion criteria

* Patients with other anal conditions, diabetic patients, patients under steroid or immunosuppressive therapy will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Time to complete anal Wound healingSix weeks after surgeryThe time required to achieve complete Complete epithelization of the anal wound postoperatively

Secondary

MeasureTime frameDescription
Anal painone week, one month, two months after surgerypain assessed using visual analogue scale from 0-10

Countries

Egypt

Contacts

Primary ContactSameh H Emile, M.D.
sameh200@hotmail.com+201006267150
Backup ContactSameh H Emile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026